Download PDF
CC BY 4.0 · Journal of Child Science 2021; 11(01): e233-e239
DOI: 10.1055/s-0041-1735537
Original Article

Clinical Profiles, Congenital Heart Disease, and Other Comorbidities Among Egyptian Children with Down Syndrome: A Tertiary Center Study

Radwa Ezzat Amin 
1   Department of Pediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt
,
Iman Ehsan Abdel-Meguid
1   Department of Pediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt
,
Nihal Mohamed El-Refaie
1   Department of Pediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt
,
Walaa Fakher
2   Department of Psychiatry, Faculty of Medicine, Cairo University, Cairo, Egypt
,
Dina El-Tabie
2   Department of Psychiatry, Faculty of Medicine, Cairo University, Cairo, Egypt
,
Hala Ahmed El-Gindy
1   Department of Pediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt
› Author Affiliations Funding None.
› Further Information
   Permissions and Reprints

Abstract

Introduction Down syndrome (DS) is the most common chromosomal disorder. It is accompanied by several comorbidities, which could lead to severe morbidity and mortality. Congenital heart disease (CHD) is one of the most commonly described condition.

Objective This study aimed to determine clinical profiles, dysmorphic features, CHD, and DS associated comorbidities in a tertiary center (Cairo, Egypt).

Patients and Methods This descriptive study included 290 patients diagnosed with DS, who presented to the Clinical Genetics clinic, Cairo University Children Hospitals, from February 2018 to December 2019. The patients' ages ranged from 2 to 4 years old. All patients were evaluated by full history, clinical examination, anthropometric measurements, and assessment of developmental milestones. Patients' diagnostic investigations including karyotype, thyroid function, and echocardiography were checked.

Results The study population consisted of 290 children with DS of which 196 (67.6%) were male, 115 (40%) had CHD, the most prevalent atrial septal defect (ASD), patent ductus arteriosus (PDA), and ventricular septal defect (VSD) accounting for 10.7, 7.1, and 4.2%, respectively. Common dysmorphic features were upward slanting palpebral fissures (98.6%), hypertelorism (97.9%), and sandal gap (60.7%). Thyroid dysfunction was the second prevalent comorbidity, found in 35 patients (12.1%). Global developmental delay was reported affecting language (99%), motor (94.8%), and social (92.8%) domains.

Conclusion The prevalence of CHD among children with DS was 40% with ASD, PDA, and VSD being the commonest. Thyroid dysfunction was the second most common comorbidity. The most prevalent dysmorphic features were upward slanting palpebral fissures, hypertelorism, and sandal gap. Developmental delay was very common, language being the most affected domain.

Keywords

Down syndrome - congenital heart disease - dysmorphic features - comorbidities

Ethical Approval

Ethical approval from Ethical Committee, Faculty of Medicine, Cairo University was received prior to commencement of the study (approval number: I-250218). Informed consent was obtained from the participant's caregivers, and they were assured of confidentiality. The purpose of this study was explained to them in simple clear language and their rights to terminate their participation, without affecting care and services offered to their children was assured.




Publication History

Received: 19 December 2020

Accepted: 25 July 2021

Article published online:
07 September 2021

© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Benhaourech S, Drighil A, Hammiri AE. Congenital heart disease and Down syndrome: various aspects of a confirmed association. Cardiovasc J Afr 2016; 27 (05) 287-290
    CrossrefPubMedGoogle Scholar
  • 2 Vacca RA, Bawari S, Valenti D. et al. Down syndrome: neurobiological alterations and therapeutic targets. Neurosci Biobehav Rev 2019; 98: 234-255
    CrossrefPubMedGoogle Scholar
  • 3 Alsubie HS, Rosen D. The evaluation and management of respiratory disease in children with Down syndrome (DS). Paediatr Respir Rev 2018; 26: 49-54
    PubMedGoogle Scholar
  • 4 Abou-Youssef HS, Kamal MM, Mehaney DA. Triple test screening for Down syndrome: an Egyptian-tailored study. PLoS One 2014; 9 (10) e110370
    CrossrefPubMedGoogle Scholar
  • 5 Bittles AH, Glasson EJ. Clinical, social, and ethical implications of changing life expectancy in Down syndrome. Dev Med Child Neurol 2004; 46 (04) 282-286
    CrossrefPubMedGoogle Scholar
  • 6 Perkins A. The lowdown on Down syndrome. Nurs Made Incred Easy 2017; 15 (02) 40-46
    CrossrefPubMedGoogle Scholar
  • 7 Shalaby HMA. A study of new potential risk factors for Down syndrome in Upper Egypt. Egypt J Med Hum Genet 2011; 12 (01) 15-19
    CrossrefPubMedGoogle Scholar
  • 8 Diamandopoulos K, Green J. Down syndrome: an integrative review. J Neonatal Nurs 2018; 24 (05) 235-241
    CrossrefPubMedGoogle Scholar
  • 9 Colvin KL, Yeager ME. What people with Down Syndrome can teach us about cardiopulmonary disease. Eur Respir Rev 2017; 26 (143) 160098
    CrossrefPubMedGoogle Scholar
  • 10 Carfì A, Antocicco M, Brandi V. et al. Characteristics of adults with Down syndrome: prevalence of age-related conditions. Front Med (Lausanne) 2014; 1: 51
    PubMedGoogle Scholar
  • 11 Stefanidis K, Belitsos P, Fotinos A, Makris N, Loutradis D, Antsaklis A. Causes of infertility in men with Down syndrome. Andrologia 2011; 43 (05) 353-357
    CrossrefPubMedGoogle Scholar
  • 12 Davis MAC, Spriggs A, Rodgers A, Campbell J. The effects of a peer-delivered social skills intervention for adults with comorbid down syndrome and autism spectrum disorder. J Autism Dev Disord 2018; 48 (06) 1869-1885
    CrossrefPubMedGoogle Scholar
  • 13 Sullivan KD, Evans D, Pandey A. et al. Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation. Sci Rep 2017; 7 (01) 14818
    CrossrefPubMedGoogle Scholar
  • 14 El-Gilany A, El-Wehady A, El-Wasify M. Updating and validation of the socioeconomic status scale for health research in Egypt. East Mediterr Health J 2012; 18 (09) 962-968
    CrossrefPubMedGoogle Scholar
  • 15 Zemel BS, Pipan M, Stallings VA. et al. Growth Charts for Children With Down Syndrome in the United States. Pediatrics 2015; 136 (05) e1204-e1211
    CrossrefPubMedGoogle Scholar
  • 16 CDC. Growth charts-clinical growth charts. Published online 2000. Accessed 15 march 2021 at: https://www.cdc.gov/growthcharts/clinical_charts.Htm
    PubMedGoogle Scholar
  • 17 Feigelman S. The second year. Nelson Textbook Pediatrics. 20th ed.. Philadelphia, PA: Elsevier; 2016
    Google Scholar
  • 18 Khoshnood B, Wall S, Pryde P, Lee KS. Maternal education modifies the age-related increase in the birth prevalence of Down syndrome. Prenat Diagn 2004; 24 (02) 79-82
    CrossrefPubMedGoogle Scholar
  • 19 Dzurova D, Pikhart H. Down syndrome, paternal age and education: comparison of California and the Czech Republic. BMC Public Health 2005; 5 (01) 69
    CrossrefPubMedGoogle Scholar
  • 20 Vashist M, Kumar A. Whether paternal age effect exists as a risk factor in trisomy 21. Biosci Biotechnol Res Asia 2016; 8 (01) 247-252
    CrossrefPubMedGoogle Scholar
  • 21 Oldereid NB, Wennerholm U-B, Pinborg A. et al. The effect of paternal factors on perinatal and paediatric outcomes: a systematic review and meta-analysis. Hum Reprod Update 2018; 24 (03) 320-389
    CrossrefPubMedGoogle Scholar
  • 22 Fisch H, Hyun G, Golden R, Hensle TW, Olsson CA, Liberson GL. The influence of paternal age on down syndrome. J Urol 2003; 169 (06) 2275-2278
    CrossrefPubMedGoogle Scholar
  • 23 Thompson JA. Disentangling the roles of maternal and paternal age on birth prevalence of down syndrome and other chromosomal disorders using a Bayesian modeling approach. BMC Med Res Methodol 2019; 19 (01) 82
    CrossrefPubMedGoogle Scholar
  • 24 Kava MP, Tullu MS, Muranjan MN, Girisha KM. Down syndrome: clinical profile from India. Arch Med Res 2004; 35 (01) 31-35
    CrossrefPubMedGoogle Scholar
  • 25 Azman BZ, Ankathil R, Siti Mariam I. et al. Cytogenetic and clinical profile of Down syndrome in Northeast Malaysia. Singapore Med J 2007; 48 (06) 550-554
    PubMedGoogle Scholar
  • 26 Mokhtar MM, Abdel Aziz AM, Nazmy NA, Mahrous HS. Cytogenetic profile of Down syndrome in Alexandria, Egypt. EMHJ - East Mediterr Health J 9 1–2 37–44 2003. Published online 2003. Accessed 2003 at: https://apps.who.int/iris/handle/10665/119241
    PubMedGoogle Scholar
  • 27 Ahmed I, Ghafoor T, Samore NA, Chattha MN. Down syndrome: clinical and cytogenetic analysis. J Coll Physicians Surg Pak 2005; 15 (07) 426-429
    PubMedGoogle Scholar
  • 28 Speed RM, Johnston AW, Evans HJ. Chromosome survey of total population of mentally subnormal in North-East of Scotland. J Med Genet 1976; 13 (04) 295-306
    CrossrefPubMedGoogle Scholar
  • 29 Patterson T, Rapsey CM, Glue P. Systematic review of cognitive development across childhood in Down syndrome: implications for treatment interventions. J Intellect Disabil Res 2013; 57 (04) 306-318
    CrossrefPubMedGoogle Scholar
  • 30 Aoki S, Yamauchi Y, Hashimoto K. Developmental trend of children with Down syndrome - How do sex and neonatal conditions influence their developmental patterns?. Brain Dev 2018; 40 (03) 181-187
    CrossrefPubMedGoogle Scholar
  • 31 Keusch GT. The history of nutrition: malnutrition, infection and immunity. J Nutr 2003; 133 (01) 336S-340S
    CrossrefPubMedGoogle Scholar
  • 32 Osaili TM, Attlee A, Naveed H. et al. Physical status and parent-child feeding behaviours in children and adolescents with Down syndrome in the United Arab Emirates. Int J Environ Res Public Health 2019; 16 (13) E2264
    CrossrefPubMedGoogle Scholar
  • 33 Senna Rodrigues B, Campos Pellanda L, Andreatta Gottschall CB. Nutritional assessment of children and teenagers with Down syndrome and congenital cardiopathy. Rev Chil Nutr 2012; 39 (02) 151-158
    CrossrefPubMedGoogle Scholar
  • 34 Bolisetty S, Daftary A, Ewald D, Knight B, Wheaton G. Congenital heart defects in Central Australia. Med J Aust 2004; 180 (12) 614-617
    CrossrefPubMedGoogle Scholar
  • 35 Afifi HH, Abdel Azeem AA, El-Bassyouni HT, Gheith ME, Rizk A, Bateman JB. Distinct ocular expression in infants and children with Down syndrome in Cairo, Egypt: myopia and heart disease. JAMA Ophthalmol 2013; 131 (08) 1057-1066
    CrossrefPubMedGoogle Scholar
  • 36 Tosson A, Amr K, Taher M. Polymorphisms in folate-metabolizing genes as risk factors for congenital heart defects in Down syndrome in Egypt. Int J Biomed Res 2015; 6 (12) 963-966
    PubMedGoogle Scholar
  • 37 El-Gilany A-H, Yahia S, Wahba Y. Prevalence of congenital heart diseases in children with Down syndrome in Mansoura, Egypt: a retrospective descriptive study. Ann Saudi Med 2017; 37 (05) 386-392
    CrossrefPubMedGoogle Scholar
  • 38 Abbag FI. Congenital heart diseases and other major anomalies in patients with Down syndrome. Saudi Med J 2006; 27 (02) 219-222
    PubMedGoogle Scholar
  • 39 El-Attar L. Congenital heart diseases in Saudi Down syndrome children: frequency and patterns in Almadinah Region. Res J Cardiol 2015; 8 (01) 20-26
    CrossrefPubMedGoogle Scholar
  • 40 Morsy MM, Algrigri OO, Salem SS. et al. The spectrum of congenital heart diseases in down syndrome. A retrospective study from Northwest Saudi Arabia. Saudi Med J 2016; 37 (07) 767-772
    CrossrefPubMedGoogle Scholar
  • 41 Elmagrpy Z, Rayani A, Shah A, Habas E, Aburawi EH. Down syndrome and congenital heart disease: why the regional difference as observed in the Libyan experience?. Cardiovasc J Afr 2011; 22 (06) 306-309
    CrossrefPubMedGoogle Scholar
  • 42 El-Shazali O, Ahmed H, El-Shazali H. The spectrum of congenital heart defects in infants with Down's syndrome, Khartoum, Sudan. J Pediatr Neonatal Care 2015; 2 (05) 00091
    CrossrefPubMedGoogle Scholar
  • 43 Poursadegh Zonouzi AA, Ahangari N, Rajai S, Poursadegh Zonouzi A, Akbarzadeh Laleh M, Nejatizadeh A. Congenital heart defects among Down syndrome patients: a clinical profiling. J Public Health 2016; 24 (01) 57-63
    CrossrefPubMedGoogle Scholar
  • 44 Kim M-A, Lee YS, Yee NH, Choi JS, Choi JY, Seo K. Prevalence of congenital heart defects associated with Down syndrome in Korea. J Korean Med Sci 2014; 29 (11) 1544-1549
    CrossrefPubMedGoogle Scholar
  • 45 Bergström S, Carr H, Petersson G. et al. Trends in congenital heart defects in infants with Down Syndrome. Pediatrics 2016; 138 (01) e20160123-e20160123
    CrossrefPubMedGoogle Scholar
  • 46 Mokhtar MM, Abdel-Fattah M. Major birth defects among infants with Down's syndrome in Alexandria, Egypt (1995-2000). J Trop Pediatr 2002; 48 (04) 247-249
    CrossrefPubMedGoogle Scholar
  • 47 Freeman SB, Taft LF, Dooley KJ. et al. Population-based study of congenital heart defects in Down syndrome. Am J Med Genet 1998; 80 (03) 213-217
    CrossrefPubMedGoogle Scholar
  • 48 Vis JC, Duffels MGJ, Winter MM. et al. Down syndrome: a cardiovascular perspective. J Intellect Disabil Res 2009; 53 (05) 419-425
    CrossrefPubMedGoogle Scholar
  • 49 Jacobs EGJ, Leung MP, Karlberg J. Distribution of symptomatic congenital heart disease in Hong Kong. Pediatr Cardiol 2000; 21 (02) 148-157
    CrossrefPubMedGoogle Scholar
  • 50 Vida VL, Barnoya J, Larrazabal LA, Gaitan G, de Maria Garcia F, Castañeda AR. Congenital cardiac disease in children with Down's syndrome in Guatemala. Cardiol Young 2005; 15 (03) 286-290
    CrossrefPubMedGoogle Scholar
  • 51 Hardy O, Worley G, Lee MM. et al. Hypothyroidism in Down syndrome: screening guidelines and testing methodology. Am J Med Genet A 2004; 124A (04) 436-437
    CrossrefPubMedGoogle Scholar
  • 52 Oyenusi EE, Ajayi EO, Akeredolu FD, Oduwole AO. Pattern of thyroid disorders in children and adolescents seen at the Lagos University Teaching Hospital, Nigeria, over a 10-year period. Niger Med J 2017; 58 (03) 101-106
    CrossrefPubMedGoogle Scholar
  • 53 Gibson PA, Newton RW, Selby K, Price DA, Leyland K, Addison GM. Longitudinal study of thyroid function in Down's syndrome in the first two decades. Arch Dis Child 2005; 90 (06) 574-578
    CrossrefPubMedGoogle Scholar